ResMed Inc (RMD)
244.28
+1.81
(+0.75%)
USD |
NYSE |
Nov 01, 16:00
244.26
-0.02
(-0.01%)
After-Hours: 20:00
ResMed Total Liabilities (Quarterly): 2.027B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.027B |
| June 30, 2024 | 2.008B |
| March 31, 2024 | 2.185B |
| December 31, 2023 | 2.423B |
| September 30, 2023 | 2.490B |
| June 30, 2023 | 2.622B |
| March 31, 2023 | 2.781B |
| December 31, 2022 | 2.938B |
| September 30, 2022 | 1.745B |
| June 30, 2022 | 1.735B |
| March 31, 2022 | 1.626B |
| December 31, 2021 | 1.589B |
| September 30, 2021 | 1.703B |
| June 30, 2021 | 1.842B |
| March 31, 2021 | 1.876B |
| December 31, 2020 | 1.708B |
| September 30, 2020 | 1.942B |
| June 30, 2020 | 2.090B |
| March 31, 2020 | 2.254B |
| December 31, 2019 | 2.096B |
| September 30, 2019 | 2.037B |
| June 30, 2019 | 2.035B |
| March 31, 2019 | 2.077B |
| December 31, 2018 | 1.904B |
| September 30, 2018 | 1.167B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.005B |
| March 31, 2018 | 1.467B |
| December 31, 2017 | 1.544B |
| September 30, 2017 | 1.440B |
| June 30, 2017 | 1.508B |
| March 31, 2017 | 1.568B |
| December 31, 2016 | 1.612B |
| September 30, 2016 | 1.550B |
| June 30, 2016 | 1.562B |
| March 31, 2016 | 771.20M |
| December 31, 2015 | 714.74M |
| September 30, 2015 | 793.87M |
| June 30, 2015 | 594.47M |
| March 31, 2015 | 741.75M |
| December 31, 2014 | 738.11M |
| September 30, 2014 | 656.24M |
| June 30, 2014 | 602.71M |
| March 31, 2014 | 673.66M |
| December 31, 2013 | 706.64M |
| September 30, 2013 | 642.10M |
| June 30, 2013 | 600.20M |
| March 31, 2013 | 606.80M |
| December 31, 2012 | 578.86M |
| September 30, 2012 | 545.74M |
| June 30, 2012 | 530.24M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.589B
Minimum
Dec 2021
2.938B
Maximum
Dec 2022
2.084B
Average
2.018B
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp | 16.50B |
| Abbott Laboratories | 34.33B |
| Becton Dickinson & Co | 29.71B |
| Insulet Corp | 1.883B |
| Twist Bioscience Corp | 146.98M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.222B |
| Shareholders Equity (Quarterly) | 5.195B |
| Debt to Equity Ratio | 0.1304 |
| Current Ratio | 2.921 |
| Net Debt Paydown Yield | 0.43% |